179 related articles for article (PubMed ID: 21949405)
1. Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis.
Crawford MA; Lowe DE; Fisher DJ; Stibitz S; Plaut RD; Beaber JW; Zemansky J; Mehrad B; Glomski IJ; Strieter RM; Hughes MA
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17159-64. PubMed ID: 21949405
[TBL] [Abstract][Full Text] [Related]
2. CXCL10 Acts as a Bifunctional Antimicrobial Molecule against Bacillus anthracis.
Margulieux KR; Fox JW; Nakamoto RK; Hughes MA
mBio; 2016 May; 7(3):. PubMed ID: 27165799
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.
Crawford MA; Zhu Y; Green CS; Burdick MD; Sanz P; Alem F; O'Brien AD; Mehrad B; Strieter RM; Hughes MA
Infect Immun; 2009 Apr; 77(4):1664-78. PubMed ID: 19179419
[TBL] [Abstract][Full Text] [Related]
4. Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.
Crawford MA; Burdick MD; Glomski IJ; Boyer AE; Barr JR; Mehrad B; Strieter RM; Hughes MA
PLoS Pathog; 2010 Nov; 6(11):e1001199. PubMed ID: 21124994
[TBL] [Abstract][Full Text] [Related]
5. The Opp (AmiACDEF) Oligopeptide Transporter Mediates Resistance of Serotype 2 Streptococcus pneumoniae D39 to Killing by Chemokine CXCL10 and Other Antimicrobial Peptides.
Bruce KE; Rued BE; Tsui HT; Winkler ME
J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29581408
[TBL] [Abstract][Full Text] [Related]
6. CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens.
Crawford MA; Fisher DJ; Leung LM; Lomonaco S; Lascols C; Cannatelli A; Giani T; Rossolini GM; Doi Y; Goodlett DR; Allard MW; Sharma SK; Khan E; Ernst RK; Hughes MA
mBio; 2017 Nov; 8(6):. PubMed ID: 29138303
[TBL] [Abstract][Full Text] [Related]
7. Disparate Regions of the Human Chemokine CXCL10 Exhibit Broad-Spectrum Antimicrobial Activity against Biodefense and Antibiotic-Resistant Bacterial Pathogens.
Crawford MA; Ward AE; Gray V; Bailer P; Fisher DJ; Kubicka E; Cui Z; Luo Q; Gray MC; Criss AK; Lum LG; Tamm LK; Letteri RA; Hughes MA
ACS Infect Dis; 2023 Jan; 9(1):122-139. PubMed ID: 36475632
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization and evaluation of protective efficacy of EA752-862 monoclonal antibody against B. anthracis vegetative cell and spores.
Majumder S; Das S; Kingston J; Shivakiran MS; Batra HV; Somani VK; Bhatnagar R
Med Microbiol Immunol; 2020 Apr; 209(2):125-137. PubMed ID: 31811379
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity and regulation of CXCL9 and CXCL10 in oral keratinocytes.
Marshall A; Celentano A; Cirillo N; Mignogna MD; McCullough M; Porter S
Eur J Oral Sci; 2016 Oct; 124(5):433-439. PubMed ID: 27671889
[TBL] [Abstract][Full Text] [Related]
10. Bacillus anthracis Responds to Targocil-Induced Envelope Damage through EdsRS Activation of Cardiolipin Synthesis.
Laut CL; Perry WJ; Metzger AL; Weiss A; Stauff DL; Walker S; Caprioli RM; Skaar EP
mBio; 2020 Mar; 11(2):. PubMed ID: 32234818
[No Abstract] [Full Text] [Related]
11. Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity.
Schutte KM; Fisher DJ; Burdick MD; Mehrad B; Mathers AJ; Mann BJ; Nakamoto RK; Hughes MA
Infect Immun; 2016 Jan; 84(1):320-8. PubMed ID: 26553462
[TBL] [Abstract][Full Text] [Related]
12. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
[TBL] [Abstract][Full Text] [Related]
13. Human chemokines as antimicrobial peptides with direct parasiticidal effect on Leishmania mexicana in vitro.
Söbirk SK; Mörgelin M; Egesten A; Bates P; Shannon O; Collin M
PLoS One; 2013; 8(3):e58129. PubMed ID: 23533582
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
Cybulski RJ; Sanz P; McDaniel D; Darnell S; Bull RL; O'Brien AD
Vaccine; 2008 Sep; 26(38):4927-39. PubMed ID: 18657585
[TBL] [Abstract][Full Text] [Related]
15. Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.
Louie A; VanScoy BD; Brown DL; Kulawy RW; Heine HS; Drusano GL
Antimicrob Agents Chemother; 2012 Mar; 56(3):1229-39. PubMed ID: 22155821
[TBL] [Abstract][Full Text] [Related]
16. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins.
Rivera J; Cordero RJ; Nakouzi AS; Frases S; Nicola A; Casadevall A
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19002-7. PubMed ID: 20956325
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization.
Cote CK; Bozue J; Moody KL; DiMezzo TL; Chapman CE; Welkos SL
Microbiology (Reading); 2008 Feb; 154(Pt 2):619-632. PubMed ID: 18227265
[TBL] [Abstract][Full Text] [Related]
18. Innate Immune Interactions between
Liu JZ; Ali SR; Bier E; Nizet V
Front Cell Infect Microbiol; 2018; 8():2. PubMed ID: 29404280
[No Abstract] [Full Text] [Related]
19. Mechanistic insights and therapeutic opportunities of antimicrobial chemokines.
Crawford MA; Margulieux KR; Singh A; Nakamoto RK; Hughes MA
Semin Cell Dev Biol; 2019 Apr; 88():119-128. PubMed ID: 29432954
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
